Merck & Co’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Hold
1,739,768
5.42% 4
2025
Q1
$15.7M Hold
1,739,768
9.57% 4
2024
Q4
$30.1M Buy
+1,739,768
New +$30.1M 11.66% 4